205 related articles for article (PubMed ID: 3908746)
1. [Tumor markers in gastrointestinal cancer].
Shimano T; Monden T; Oji Y; Morimoto H; Tomita N; Mori T
Rinsho Byori; 1985 Aug; 33(8):853-60. PubMed ID: 3908746
[No Abstract] [Full Text] [Related]
2. [Crucial diagnostic points of tumor markers: gastrointestinal tumors].
Klöppel G
Verh Dtsch Ges Pathol; 1986; 70():159-71. PubMed ID: 2435072
[No Abstract] [Full Text] [Related]
3. Immunological diagnosis and prognosis of digestive tract cancer: some clinical considerations.
Zamcheck N
Ann Immunol (Paris); 1973 Nov; 124(4):635-40. PubMed ID: 4792503
[No Abstract] [Full Text] [Related]
4. [New monoclonal antibodies in the diagnosis of gastrointestinal cancers].
Heptner G; Domschke S; Domschke W
Internist (Berl); 1986 Nov; 27(11):723-8. PubMed ID: 2433247
[No Abstract] [Full Text] [Related]
5. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
[No Abstract] [Full Text] [Related]
6. Strategies for heterogeneous enzyme immunoassays for tumor markers.
King WJ; Tomita JT; Dowell BL; Delfert DM
Immunol Ser; 1990; 53():83-93. PubMed ID: 1713072
[No Abstract] [Full Text] [Related]
7. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (2)].
Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1907-12. PubMed ID: 2439021
[TBL] [Abstract][Full Text] [Related]
8. [Ganglioside and carcinoembryonic antigens in the diagnosis of malignant tumors of the gastrointestinal tract].
Ivanov PK; Samoĭlenko VM
Vopr Onkol; 1984; 30(9):55-9. PubMed ID: 6495695
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of TPA-assay kit using monoclonal antibodies].
Saga T; Sakahara H; Kousaka T; Yao Z; Nakamoto Y; Hattori N; Zhang M; Nakayama M; Ohshio G; Imamura M; Konishi J
Gan To Kagaku Ryoho; 1996 Apr; 23(5):615-21. PubMed ID: 8678521
[TBL] [Abstract][Full Text] [Related]
10. [Tag 72: a new tumor-associated antigen identified by a monoclonal antibody].
Piantino P; Fusaro A; Daziano E; Polloni R; Mosso R; Cacace G
Minerva Med; 1990 Nov; 81(11):765-7. PubMed ID: 2255410
[TBL] [Abstract][Full Text] [Related]
11. [CA-19-9, CA50 and CEA in pancreatic and gastrointestinal tumors. Comparative studies].
Dienst C; Clodius T; Oldörp T; Uhlenbruck G; Diehl V
Med Klin (Munich); 1987 Jan; 82(2):45-50. PubMed ID: 3470595
[No Abstract] [Full Text] [Related]
12. [Fundamental studies and reference values of cancer associated antigen NCC-ST-439].
Yoshioka H; Sakurabayashi I; Kawai T; Suzuki M
Rinsho Byori; 1987 Nov; 35(11):1233-8. PubMed ID: 3327976
[No Abstract] [Full Text] [Related]
13. [Evaluation of a monoclonal antibody (CA 19-9 system) in gastrointestinal disease--in comparison with CEA and IAP].
Furukawa M; Kozaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
Nihon Gan Chiryo Gakkai Shi; 1985 Feb; 20(1):25-30. PubMed ID: 3858395
[No Abstract] [Full Text] [Related]
14. [Basic studies and the reference values of cancer associated antigen CA-50].
Yoshioka H; Shitara M; Sakurabayashi I; Kawai T; Suzuki M
Rinsho Byori; 1988 Feb; 36(2):171-6. PubMed ID: 3288785
[No Abstract] [Full Text] [Related]
15. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
Klapdor R; Greten H
Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
[No Abstract] [Full Text] [Related]
16. [Clinical and prognostic significance of determining the carcinoembryonic antigen in patients with gastrointestinal cancer].
Vlakhov N; Dimitrova S; Koev Ch; Vladimirov V; Bozhinov T
Vopr Onkol; 1986; 32(2):73-6. PubMed ID: 3962245
[TBL] [Abstract][Full Text] [Related]
17. The role of tumor markers in the diagnosis and management of gastrointestinal cancer.
Heptner G; Domschke S; Domschke W
Hepatogastroenterology; 1986 Aug; 33(4):140-4. PubMed ID: 2428718
[No Abstract] [Full Text] [Related]
18. Monoclonal antibodies in the diagnosis and treatment of malignant conditions.
Allum WH; Macdonald F; Fielding JW
Surg Annu; 1986; 18():41-64. PubMed ID: 2417343
[No Abstract] [Full Text] [Related]
19. Monoclonal antibodies to human mammary carcinoma associated antigens and their potential uses for diagnosis, prognosis, and therapy.
Colcher D; Hand PH; Wunderlich D; Nuti M; Teramoto YA; Kufe D; Schlom J
Lab Res Methods Biol Med; 1983; 8():215-58. PubMed ID: 6358744
[No Abstract] [Full Text] [Related]
20. [Immunologic markers of pancreatic cancer in humans].
Kulagin PP; Chalov VV
Vopr Onkol; 1983; 29(8):62-7. PubMed ID: 6193639
[No Abstract] [Full Text] [Related]
[Next] [New Search]
